Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
422 participants
INTERVENTIONAL
2013-10-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigator hypothesizes that the level of knowledge about the benefits of physical activity, physical activity level and physical fatigue level observed in cancer patients, would influence their beliefs about physical activity and their intention to engage in AP.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Cancer Center Based Physical Activity Intervention
NCT01173861
Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients
NCT03210129
Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors
NCT03131440
Studying Tailored Exercise Prescriptions in Breast Cancer Patients
NCT02802826
Physical Exercise Benefits for Cancer Patients
NCT06275321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Because of a recent research, it is shown that a narrative message from a peer generates an identification, a sense of self-efficacy and intention to practice in sedentary patients with breast cancer.
The investigator hypothesize that a promotional message about physical activity, issued by a self-determined peer (intrinsic motivation), compared to a non-self-determined peer (extrinsic motivation), generate higher scores of positive beliefs about physical activity and intention to engage in a physical activity program for sedentary patients.
These promotional messages will be delivered through two videos, one featuring the self-determined pair, the other featuring the non-self-determined pair.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Physical activity motivation
Physical activity motivation
Physical activity motivation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity motivation
Physical activity motivation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with breast cancer undergoing chemotherapy treatment
* neoadjuvant, adjuvant, metastatic, any histological type, any stage breast cancer
* Sedentary Patients (physical activity score of Dijon less than or equal to 20)
Exclusion Criteria
* Patients with cognitive disorders not allowing them to understand the questionnaires and study procedures
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Antoine Lacassagne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Véronique MARI, md
Role: PRINCIPAL_INVESTIGATOR
Centre Antoine Lacassagne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Antoine LACASSAGNE
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01015-40
Identifier Type: OTHER
Identifier Source: secondary_id
2013/03 RESCA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.